BioSpace News Archive

Nexus Pharmaceuticals, Inc. is pleased to announce that it has received authorization to occupy its new pharmaceutical manufacturing facility from the Village of Pleasant Prairie, Wisconsin.

The Academic Orthopedic Consortium Women’s Leadership Forum powered by Breg proudly honors Orthopaedic Surgeon Leader Kristy Weber, MD who served as the 1st female President of the American Academy of Orthopedic Surgeons in 2019.

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today reported financial results and operational updates for the quarter and year ended December 31, 2020.

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it will report financial results for the fourth quarter and full year 2020 after the close of U.S. markets on Tuesday, March 30, 2021.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) has provided its financial results for the fourth quarter and full year ended December 31, 2020

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T-cell-driven research, today announced the closing of its initial public offering of 12,937,500 American Depositary Shares (“ADSs”), representing 12,937,500 ordinary shares of the Company,

Aptose Biosciences Inc., a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, announced financial results for the year and three months ended December 31, 2020 and a corporate update.

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced fourth quarter and full year 2020 results and provided a corporate update.

Increased testing capacity and an extensive network of testing laboratories combined with support from Color, a leading software and logistics provider, will enable safe, sustainable in-person instruction

CONMED Corporation announced that its Annual Meeting of Stockholders will be held as a virtual meeting on Wednesday, May 19, 2021, at 1:30 p.m. ET.